Assessing the quality of reporting in artificial intelligence/machine learning research for cardiac amyloidosis.
Despite the rapid development of AI in clinical medicine, reproducibility and methodological limitations hinder its clinical utility. In response, MINimum Information for Medical AI Reporting (MINIMAR) standards were introduced to enhance publication standards and reduce bias, but their application remains unexplored. In this review, we sought to assesses the quality of reporting in AI/ML studies of cardiac amyloidosis (CA) an increasingly important cause of heart failure.
Author(s): Arefeen, Asiful, Singh, Simar, Razavi, Crystal, Ghasemzadeh, Hassan, Dev, Sandesh
DOI: 10.1093/jamiaopen/ooaf104